| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |